Don't pay just to have an ISA. Find out more

(AGI.L) AGI Therapeutics PLC Buy/Sell

Add to portfolio Set Alert Level 2 Desktop Trader

Summary

Current Market Information

Time: 04:58 (Market Closed)

Bid	4.00
Ask	6.00
Price	5.00
Previous	5.00
Change	+0 p (0.0000%)
Last Trade	5 (16:35:25)
Trading Vol.	9,285
Today's High	5.36
Today's Low	5.35

52 Wk Low	3.80
52 Wk Low	(10/02/2010)
52 Wk High	43.00
52 Wk High	(11/05/2009)
52 Wk Change	-13.50
52 Wk Change	(-72.97%)
4 Wk Volume	20,082
ISIN Number	IE00B0YT0Q82
Currency	GBX

More Trades Info

Performance Graph
3 month closing prices

More Chart Options

Fundamentals
Operating Profit (m)

More AGI.L Research

Sector Heat Map

1 Month Biggest Movers

More Sector Analysis

Recent News
Date/Time	Headline	Source
10-03-10	AGI Therapeutics plc - Notice of Results	RNS
RNS Number : 3883I AGI Therapeutics plc 10 March 2010 AGI Therapeutics PLC Notification of Results AGI Therapeutics plc ("AGI" or the "Company") (AIM, IEX: AGI), a speciality pharmaceutical company, will be announcing its preliminary results for the year ended 31 December 2009 on Wednesday, 14th April 2009. Contact Information: `AGI Therapeutics plc. Tel: +353 1 449 3254` David Kelly, Chief Financial Officer `Davy Tel: +353 (1) 614 6363` John Frain Notes to Editors: About AGI Therapeutics plc AGI is a specialty pharmaceutical company which is focused on the development and commercialisation of differentiated specialty drug products to treat unmet medical needs, including conditions which qualify for Orphan drug status. The Company aims to bring its products to the market either directly or through out-licensing or other partnering arrangements. AGI's common shares are listed on the Alternative Investment Market of the London Stock Exchange (AIM) and on the Irish Enterprise Exchange of the Irish Stock Market (IEX) as AGI. For further information please see www.agitherapeutics.com This information is provided by RNS The company news service from the London Stock Exchange END NORMMGMFKGGGGZM More
11-02-10	AGI Therapeutics plc - Holding(s) in Company	RNS
RNS Number : 0112H AGI Therapeutics plc 11 February 2010 AGI Therapeutics plc ('AGI') Holding in Company AGI was notified on 10 February 2010 that Edinburgh Partners Limited had decreased its shareholding to 2,569,576 Ordinary Shares representing 3.81% of AGI's Issued Share Capital. On 11 February 2010 AGI was notified that Edinburgh Partners Limited no longer had a notifiable interest in AGI's Issued Share Capital. Contact Information AGI Therapeutics `David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254` This information is provided by RNS The company news service from the London Stock Exchange END HOLUAARRRSAUAAR More
10-02-10	AGI Therapeutics plc - Holding(s) in Company	RNS
RNS Number : 9414G AGI Therapeutics plc 10 February 2010 AGI Therapeutics plc ('AGI') Holding in Company AGI was notified on 9 February 2010 that Edinburgh Partners Limited, having assumed management of certain funds previously managed by F&C Management Limited, had decreased its shareholding to 2,969,576 Ordinary Shares representing 4.41% of AGI's Issued Share Capital. Contact Information AGI Therapeutics `David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254` This information is provided by RNS The company news service from the London Stock Exchange END HOLURVKRRWAUARR More
19-01-10	AGI Therapeutics plc - Award of Options to Directors	RNS
RNS Number : 7802F AGI Therapeutics plc 19 January 2010 AGI Therapeutics plc ("AGI" or the "Company") Award of Options to Directors On 18th January, 2010, AGI awarded the following options over ordinary shares of EUR0.01 each in the share capital of the Company ("Ordinary Shares") with an exercise price of EUR0.08 in accordance with the Company's share option scheme. `Director Number of options Resulting number` `over Ordinary Shares of options held` granted `John Devane 1,260,000 3,290,160` `Mary Martin 1,260,000 2,775,596` `Patrick Ashe 840,000 2,355,596` `David Kelly 840,000 2,355,596` Ends This information is provided by RNS The company news service from the London Stock Exchange END RDSEAFFNFSNEEFF More

More...

1 to 4 of 12 Messages

Post New Message
Date/Time	Subject	Author
02-10-09	Rezular	landmark2002


	View Author's profile \| Add to favourites \| Ignore \| Author's posts
	Agi now says that it aims to pursue development of the drug Rezular for other diarrhea-related indications and potentially for one indication in a completely different disease field. The company has also realigned its business strategy and is opening up its development programs to nongastrointestinal specialty areas of unmet needs. AGI has a pipeline of clinical-stage candidates that are either isomers or new drug delivery formulations of existing approved drugs. The company is therefore planning to continue development of the drug for other chronic diarrhea-associated indications potentially including orphan indications, which together could lead to peak sales of some $1 billion. AGI also hinted that it has identified a new orphan indication outside the area of gastrointestinal therapeutics, for which it believes Rezular may have unique benefits and a sales potential of some $500 million. More \| View thread (1) \| Respond \| Login to Vote up
12-07-09	Re: LONG DIPPER	markytosh14


	View Author's profile \| Add to favourites \| Ignore \| Author's posts
	Down further probably !! New drugs research failed test . Say no more they are not GSK . More \| View thread (7) \| Respond \| Login to Vote up
22-06-09	Re: LONG DIPPER	landmark2002


	View Author's profile \| Add to favourites \| Ignore \| Author's posts
	Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. AGI is BEARISH in short-term; and NEUTRAL in mid-long term. Stock has closed above bottom band by 0.7%. Bollinger Bands are 75% narrower than normal. This suggests low volatility. The bands have been in this narrow range for 11 bars. May be about to initiate a new trend. More \| View thread (7) \| Respond \| Login to Vote up
15-05-09	Re: Big DIPPER	chopper89x


	View Author's profile \| Add to favourites \| Ignore \| Author's posts
	haa this rns makes me laugh more than any iv seen, full of shi* and their product couldnt get it out properly More \| View thread (7) \| Respond \| Login to Vote up

The contents of the postings summarised here represents the opinions of the authors and not of Interactive Investor Trading Limited.
They have not been approved or issued by Interactive Investor Trading Limited.

Discussion Board Terms & Conditions FSA Market Abuse Fact Sheet

More...